Sun Pharma Advanced Research Company announced on Friday that it has entered into a licensing agreement with cancer drug maker Biomodifying. As per the license agreement, Sun Pharma Advanced Research would acquire the right to license the biotech company's intellectual property, including all its patents and patent application along with antibodies developed for multiple purposes, including that of cancer ailment.